Chugai Pharmaceutical Co., Ltd.

Chugai Pharmaceutical was founded in 1925. It entered into a strategic alliance with Roche in October 2002, becoming a member of the Roche Group.

As a drug manufacturer and a pioneer in biotechnological and pharmaceutical research, Chugai is a leading presence in the Japanese therapeutic antibody market and has gained reputation worldwide for its proprietary antibody engineering technologies.

Chugai has over 7,500 employees and has its headquarters situated in Tokyo, Japan.